Larimar Therapeutics, Inc. (LRMR)
2.27
0.00 (0.00%)
USD |
NASDAQ |
Oct 23, 10:27
Larimar Therapeutics Market Cap : 236.95M for Oct. 23, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 22, 2026 | 236.95M |
| October 21, 2026 | 252.61M |
| October 20, 2026 | 254.69M |
| October 19, 2026 | 221.29M |
| October 16, 2026 | 207.20M |
| October 15, 2026 | 207.72M |
| October 14, 2026 | 218.16M |
| October 13, 2026 | 225.47M |
| October 12, 2026 | 264.09M |
| October 09, 2026 | 278.70M |
| October 08, 2026 | 281.83M |
| October 07, 2026 | 287.05M |
| October 06, 2026 | 290.18M |
| October 05, 2026 | 298.54M |
| October 02, 2026 | 308.97M |
| October 01, 2026 | 319.41M |
| September 30, 2026 | 333.50M |
| September 29, 2026 | 327.76M |
| September 28, 2026 | 330.89M |
| September 25, 2026 | 320.98M |
| September 24, 2026 | 346.55M |
| September 23, 2026 | 403.44M |
| September 22, 2026 | 398.74M |
| September 21, 2026 | 399.79M |
| September 18, 2026 | 395.61M |
| Date | Value |
|---|---|
| September 17, 2026 | 396.66M |
| September 16, 2026 | 410.22M |
| September 15, 2026 | 408.14M |
| September 14, 2026 | 394.57M |
| September 11, 2026 | 409.18M |
| September 10, 2026 | 401.87M |
| September 09, 2026 | 403.96M |
| September 08, 2026 | 425.36M |
| September 04, 2026 | 399.79M |
| September 03, 2026 | 399.79M |
| September 02, 2026 | 403.96M |
| September 01, 2026 | 411.27M |
| August 31, 2026 | 398.74M |
| August 28, 2026 | 418.58M |
| August 27, 2026 | 422.75M |
| August 26, 2026 | 435.28M |
| August 25, 2026 | 434.23M |
| August 24, 2026 | 422.75M |
| August 21, 2026 | 436.32M |
| August 20, 2026 | 434.23M |
| August 19, 2026 | 443.63M |
| August 18, 2026 | 423.79M |
| August 17, 2026 | 450.93M |
| August 14, 2026 | 455.11M |
| August 13, 2026 | 445.72M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ACADIA Pharmaceuticals, Inc. | 3.403B |
| Alnylam Pharmaceuticals, Inc. | 29.98B |
| Anika Therapeutics, Inc. | 282.25M |
| Savara, Inc. | 866.79M |
| Vericel Corp. | 2.178B |
Market Cap Related Metrics
| PEG Ratio | -0.0424 |
| Price to Book Value | 1.860 |
| Price | 2.27 |
| Earnings Yield | -87.36% |
| PEGY Ratio | -0.0424 |